Therapeutics: Solute carrier family 28 member 2 (SLC28A2; CNT2)

Endocrine/metabolic disease

INDICATION: Hyperuricemia / gout

In vitro and rat studies identified a

Read the full 110 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE